Viewing StudyNCT05303129



Ignite Creation Date: 2024-05-06 @ 5:26 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05303129
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-09
First Post: 2022-03-21

Brief Title: Prognostic Impact of the NeutrophilLymphocyte Ratio NLR in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK46 Inhibitor
Sponsor: Centre Francois Baclesse
Organization: Centre Francois Baclesse

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-27
Start Date Type: ACTUAL
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06
Completion Date Type: ESTIMATED
First Submit Date: 2022-03-21
First Submit QC Date: March 21 2022
Study First Post Date: 2022-03-31
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-08
Last Update Post Date: 2024-01-09
Last Update Post Date Type: ACTUAL